NCT06573424 2025-05-01
Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Completed
Clinical Trials
3 trialsNCT06367010 2024-04-16
Clinical Efficacy of 125I Brachytherapy Combined With Anlotinib in Radioiodine Refractory Thyroid Carcinoma Patients
Jiangxi Provincial Cancer Hospital
Completed
NCT05303740 2022-03-31
Anlotinib Retrospective Study for Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University
Completed